Nomura Holdings’ U.S.-listed ADR (NMR) fell roughly 3.8% to $7.96 in Thursday trading as Japan-linked financial names stayed under pressure in a risk-off tape. Japanese equities have recently been hit by a sharp currency move and broader de-risking, with the yen’s break past ¥160 per dollar cited as a catalyst for a renewed equity slump and higher volatility—conditions that typically weigh on broker-dealer shares tied to trading activity, investment appetite, and mark-to-market sentiment. (japantimes.co.jp)

Beyond the macro backdrop, investors have also been digesting signals of a modestly thinner capital cushion. In Nomura’s February 2026 Form 6-K covering the nine months ended December 31, 2025, the firm reported a common equity Tier 1 (CET1) ratio of 12.8% (down versus the prior fiscal year-end) while risk-weighted assets rose, a combination that can amplify downside sensitivity on weak tape days for capital-marked financials. (nomuraholdings.com)

Nomura still has shareholder-return support in the background via its board-authorized repurchase program running from February 17, 2026 to September 30, 2026 (with blackout periods around results). But when markets turn risk-off, buybacks often take a back seat to balance-sheet optics, and traders tend to re-price earnings cyclicality in broker-dealers more quickly than they do for less market-sensitive financials. (nomuraholdings.com)

Near-term direction for NMR is likely to track (1) yen volatility, (2) Japan equity risk appetite, and (3) any incremental capital/balance-sheet disclosures ahead of the company’s next results window. Investors will also be monitoring whether the current environment meaningfully changes the pace of repurchases under the existing authorization.